Exendin-4 analogs in insulinoma theranostics.
J Labelled Comp Radiopharm · 2019
Last updated 2026-05-28| Journal | J Labelled Comp Radiopharm, 2019 |
|---|---|
| Citations | 54 |
| Relative citation ratio | 3.15 |
| NIH percentile | 85 |
| Molecules | — |
Abstract
Insulinomas, neuroendocrine tumors arising from pancreatic beta cells, often show overexpression of the glucagon-like peptide-1 receptor. Therefore, imaging with glucagon-like peptide analog exendin-4 can be used for diagnosis and preoperative localization. This review presents an overview of the development and clinical implementation of exendin-based tracers for nuclear imaging, and the potential use of exendin-4 based tracers for optical imaging and therapeutic applications such as peptide receptor radionuclide therapy or targeted photodynamic therapy.
Verbatim abstract via PubMed 31070270 ↗